SCHEMBL2229634

SCHEMBL2229634

O=C(O)C(Cc1c[nH]cn1)NCc1ccccc1O

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 1/20 0.41
▸ MAPK1 P28482 1/20 0.41
▸ GAA P10253 1/20 0.37
▸ HIF1A Q16665 2/20 0.36
▸ CYP2D6 P10635 1/20 0.36
▸ TSHR P16473 1/20 0.36
▸ AKR1B1 P15121 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.35
▸ HPGD P15428 1/20 0.35
▸ CA12 O43570 2/20 0.35
▸ CA2 P00918 2/20 0.35
▸ PKM P14618 1/20 0.35
▸ NOX4 Q9NPH5 1/20 0.34
▸ KDM4E B2RXH2 1/20 0.34
▸ CPB2 Q96IY4 3/20 0.34
▸ CPB1 P15086 1/20 0.34
▸ CA9 Q16790 1/20 0.34
▸ ITGA4 P13612 1/20 0.34
▸ ITGB7 P26010 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6239442 1.00 POLB (0.41) POLBMAPK1GAAHIF1ACYP2D6
SCHEMBL2980934 0.88 CPB2 (0.38) AKR1B1CPB2CPB1
SCHEMBL7345574 0.87 KDM4E (0.43) POLBGAAALDH1A1HPGDKDM4E
SCHEMBL6240988 0.86 POLB (0.38) POLBMAPK1GAAHIF1AKDM4E
SCHEMBL466340 0.85 GAA (0.40) POLBGAAALDH1A1
SCHEMBL466341 0.85 GAA (0.40) POLBGAAALDH1A1
SCHEMBL1643961 0.85 GAA (0.40) POLBGAAALDH1A1
SCHEMBL31711243 0.83 ALDH1A1 (0.46) POLBALDH1A1KDM4E
SCHEMBL28558505 0.83 CPB2 (0.38) ALDH1A1CPB2CPB1
SCHEMBL147911 0.83 CPB2 (0.38) ALDH1A1CPB2CPB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119462458-A Covalent inhibitor of targeted hCES A and preparation method and application thereof 中国人民解放军海军军医大学 2025-02-18 — — CN disclosed
WO-2024009289-A2 METAL ORGANIC FRAMEWORK MATERIALS AND APPLICATION THEREOF IN ELECTROCATALYSIS KING KHALID UNIVERSITY (SA) 2024-01-11 — — WO disclosed
US-8623661-B2 Iron chelating agent, method for producing same, method for determining amount of iron ions and method for trapping iron ions NATIONAL UNIVERSITY CORPORATION ASAHIKAWA MEDICAL COLLEGE (JP) 2014-01-07 — — US disclosed
US-8623661-B2 Iron chelating agent, method for producing same, method for determining amount of iron ions and method for trapping iron ions NATIONAL UNIVERSITY CORPORATION ASAHIKAWA MEDICAL COLLEGE (JP) 2014-01-07 — — US disclosed
US-20110189779-A1 IRON CHELATING AGENT, METHOD FOR PRODUCING SAME, METHOD FOR DETERMINING AMOUNT OF IRON IONS AND METHOD FOR TRAPPING IRON IONS YAMAGATA UNIVERSITY (JP) 2011-08-04 — — US disclosed
US-20110189779-A1 IRON CHELATING AGENT, METHOD FOR PRODUCING SAME, METHOD FOR DETERMINING AMOUNT OF IRON IONS AND METHOD FOR TRAPPING IRON IONS YAMAGATA UNIVERSITY (JP) 2011-08-04 — — US disclosed
EP-2341774-A1 TREATMENT OF NEUROBLASTOMA WITH MULTI-ARM POLYMERIC CONJUGATES OF 7-ETHYL-10-HYDROXYCAMPTOTHECIN Enzon Pharmaceuticals, Inc. (US) 2011-07-13 — — EP disclosed
WO-2010048018-A1 TREATMENT OF NEUROBLASTOMA WITH MULTI-ARM POLYMERIC CONJUGATES OF 7-ETHYL-10-HYDROXYCAMPTOTHECIN ENZON PHARMACEUTICALS, INC. (US) 2010-04-29 — — WO disclosed
WO-2010025337-A1 METHOD OF TREATING RAS ASSOCIATED CANCER ENZON PHARMACEUTICALS, INC. (US) 2010-03-04 — — WO disclosed
EP-2073809-A2 TREATMENT OF NON-HODGKIN'S LYMPHOMAS WITH MULTI-ARM POLYMERIC CONJUGATES OF 7-ETHYL-10-HYDROXYCAMPTOTHECIN Enzon Pharmaceuticals, Inc. (US) 2009-07-01 — — EP disclosed
WO-2009060218-A1 NOVEL COMPLEXES AND A PROCESS FOR THEIR PREPARATION POLYTHERICS LIMITED (GB) 2009-05-14 — — WO disclosed
EP-1996208-A2 MULTI-ARM POLYMERIC CONJUGATES OF 7-ETHYL-10-HYDROXYCAMPTOTHECIN FOR TREATMENT OF BREAST, COLORECTAL, PANCREATIC, OVARIAN AND LUNG CANCERS Enzon Pharmaceuticals, Inc. (US) 2008-12-03 — — EP disclosed
WO-2008033643-A2 TREATMENT OF NON-HODGKIN'S LYMPHOMAS WITH MULTI-ARM POLYMERIC CONJUGATES OF 7-ETHYL-10-HYDROXYCAMPTOTHECIN ENZON PHARMACEUTICALS, INC. (US) 2008-03-20 — — WO disclosed
EP-1846412-A1 PROCESS FOR THE MANUFACTURING OF 7-ETHYL-10-HYDROXY CAMPTOTHECIN Fermion Oy (FI) 2007-10-24 — — EP disclosed
WO-2007092646-A2 MULTI-ARM POLYMERIC CONJUGATES OF 7-ETHYL-10-HYDROXYCAMPTOTHECIN FOR TREATMENT OF BREAST, COLORECTAL, PANCREATIC, OVARIAN AND LUNG CANCERS ENZON PHARMACEUTICALS, INC. (US) 2007-08-16 — — WO disclosed
WO-2006082279-A1 PROCESS FOR THE MANUFACTURING OF 7-ETHYL-10-HYDROXY CAMPTOTHECIN FERMION OY (FI) 2006-08-10 — — WO disclosed
EP-1019090-A1 POLYMERIC DERIVATIVES OF CAMPTOTHECINS PHARMACIA & UPJOHN S.p.A. (IT) 2000-07-19 — — EP disclosed
WO-1999017804-A1 POLYMERIC DERIVATIVES OF CAMPTOTHECINS PHARMACIA & UPJOHN S.P.A. (IT) 1999-04-15 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110189779-A1 IRON CHELATING AGENT, METHOD FOR PRODUCING SAME, METHOD FOR DETERMINING AMOUNT OF IRON IONS AND METHOD FOR TRAPPING IRON IONS SLC40A1, FTH1, TFRC POLB 3330/4885MAPK1 4652/4885GAA 2435/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback